Our results indicate that the SLAN-negative population of monocytes has anti-inflammatory characteristics, while the SLAN-positive population has anti-tumor characteristics in the CLL microenvironment. Here, SECISBP2L is linked to B-cell chronic lymphocytic leukemia.